Results 21 to 30 of about 3,018 (196)

Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin [PDF]

, 2016
Pityriasis rubra pilaris is a chronic inflammatory dermatosis of unknown etiology and great clinical variability. It has been divided into six categories.
Carvalho, S., Mota, F., Sanches, M., Selores, M.   +3 more
core   +1 more source

Pityriasis rubra pilaris

Dermatology Online Journal, 2003
Pityriasis rubra pilaris is a chronic, papulosquamous dermatosis of unclear etiology. The case of a 61-year-old man with pityriasis rubra pilaris is presented. The clinical forms, histopathologic features, and treatment options of pityriasis rubra pilaris are reviewed.
N. Cammarota, J. Hergocova, T. M. Lotti
  +7 more sources

Pityriasis rubra pilaris – erütrodermia haruldane põhjus. Haigusjuhu kirjeldus [PDF]

, 2017
Eütrodermia on äge dermatoloogiline seisund, mille korral esineb nahal generaliseerunud erüteem, mis haarab 85–90% kehapinnast ning millega kaasneb sageli ketendus.
Erm, Triin, Karelson, Maire, Lepasaar, Alina   +2 more
core   +2 more sources

Pityriasis Rubra Pilaris

Journal of the American Academy of Dermatology
Greiling TM, Brown F, Syed HA.
europepmc   +4 more sources

Analysis of CARD14 Polymorphisms in Pityriasis Rubra Pilaris: Activation of NF-κB. [PDF]

, 2015
Pityriasis rubra pilaris (PRP) is a rare inflammatory papulo-squamous disorder manifesting with palmoplantar keratoderma and follicular hyperkeratotic papules which tend to coalesce into large, scaly, erythematous plaques often progressing to exfoliative
Andrews, Jonathan, Fuchs-Telem, Dana, Jin Chung, Hye, Keller, Matthew, Kingman, Joshua, Li, Qiaoli, Ross, Nicholas, Sarig, Ofer, Sprecher, Eli, Uitto, Jouni   +9 more
core   +2 more sources

Beneficial effect of ustekinumab in familial pityriasis rubra pilaris with a new missense mutation in CARD14 [PDF]

, 2018
Pityriasis rubra pilaris (PRP) represents a group of rare chronic inflammatory skin disorders in which ~1 in 20 affected individuals show autosomal dominant inheritance.
Hsu, C-K, Levell, N J, Lwin, S M, McGrath, J A   +3 more
core   +1 more source

Pityriasis rubra pilaris developing after COVID-19

Turkderm Turkish Archives of Dermatology and Venereology, 2022
Coronavirus disease-2019 (COVID-19) has been associated with multiple skin lesions as well as causing common respiratory symptoms. We presented a case of pityriasis rubra pilaris that developed after COVID-19 infection and treated with anti-tumor ...
Mine Müjde Kuş, Perihan Öztürk, Hülya Nazik, Mehmet Kamil Mülayim, Tutku Bulut, Esra Rabia Akgüç, Sezen Koçarslan   +6 more
doaj   +1 more source

Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra Pilaris. [PDF]

, 2017
Treatment of pityriasis rubra pilaris (PRP) is solely based on its resemblance to psoriasis rather than any knowledge of its pathomechanism. Insight into pathogenic mediators of inflammation is essential for targeted and valid treatment options that ...
Conrad, C., Demaria, O., Feldmeyer, L., Gilliet, M., Hohl, D., Laffitte, E., Mennella, A., Mylonas, A., Yawalkar, N.   +8 more
core   +2 more sources

Pityriasis rubra pilaris presenting with an abnormal autoimmune profile: two case reports

Journal of Medical Case Reports, 2009
Introduction Pityriasis rubra pilaris is an uncommon inflammatory and hyperproliferative dermatosis of juvenile or adult onset. The etiology of the disease is still unknown.
Gregoriou Stamatis, Chiolou Zoe, Stefanaki Christina, Zakopoulou Niki, Rigopoulos Dimitrios, Kontochristopoulos George   +5 more
doaj   +1 more source

Learning differential diagnosis of erythemato-squamous diseases using voting feature intervals [PDF]

, 1998
Cataloged from PDF version of article.A new classification algorithm, called VFI5 (for Voting Feature Intervals), is developed and applied to problem of differential diagnosis of erythemato-squamous diseases.
Demiroz, G., Guvenir, H. A., Ilter, N.
core   +1 more source